PARTICIPA

PARTICIPA

martes, 27 de junio de 2023

Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels | Clinical Pharmacy and Pharmacology | JAMA Internal Medicine | JAMA Network

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2800884


Enviado desde mi iPhone

No hay comentarios:

Publicar un comentario

Danos tu opinion, enriquece el post.